Description
Semaglutide + Cagrilintide Blend is a dual-compound metabolic research peptide blend formulated for laboratory research involving GLP-1 receptor agonism and amylin-pathway signaling models
Blend Category
Metabolic Research Blend
Research Goals & Applications
- GLP-1 and amylin dual-pathway receptor signaling research
- Multi-mechanism metabolic pathway laboratory models
- Incretin and satiety signaling pathway investigation
- Comparative receptor agonism research studies
- In-vitro metabolic signaling model development
Components Included
| Compound | Role |
|---|---|
| Semaglutide | GLP-1 receptor agonist — metabolic signaling research |
| Cagrilintide | Long-acting amylin analog — amylin-pathway research |
Specifications
- Blend Type: Dual-Compound Research Blend
- Format: Lyophilized powder
- Storage: -20°C recommended, protected from light
- Purity: ≥98% per HPLC (individual components)
- Documentation: COA, HPLC report, batch record
- Usage: Research use only — not for human consumption
Quality & Documentation
- Certificate of Analysis (COA) included with every order
- Third-party HPLC and mass spectrometry testing on every production batch
- Batch-specific traceability documentation from synthesis to shipment
- Reconstitution guide and storage instructions included
- Research library access provided with purchase
For research use only. Not for human consumption. Not intended to diagnose, treat, cure, or prevent any disease. For laboratory research applications only.
Frequently Asked Questions
What is the Semaglutide + Cagrilintide Blend used for in laboratory research?
The Semaglutide + Cagrilintide Blend is a dual-compound metabolic research peptide blend formulated for laboratory investigation involving GLP-1 receptor agonism (Semaglutide) and amylin-pathway signaling (Cagrilintide) in simultaneous study designs. It is COA-verified, HPLC-tested, and supplied for research use only.
What is the research rationale for combining Semaglutide and Cagrilintide?
Semaglutide acts at the GLP-1 receptor (incretin pathway), while Cagrilintide acts at the amylin receptor (islet amyloid polypeptide pathway). Both pathways are studied in preclinical metabolic signaling research. Combined study designs examining GLP-1 and amylin co-signaling require simultaneous compound delivery at consistent ratios – a workflow this blend is designed to support.
What purity and documentation standards apply?
Both compounds are HPLC-tested at >=98% purity (lot-specific) and LC-MS identity verified. A single lot-specific COA covering both compounds ships with every order.
What is the advantage of the pre-formulated blend over sourcing each compound individually?
Consistent compound ratio vial-to-vial, a single reconstitution step rather than two, and a single lot-specific COA for both compounds in one document. This simplifies preparation documentation and eliminates the risk of batch-date misalignment when procuring GLP-1 and amylin analogs separately.
What format does the blend arrive in?
Lyophilized powder in a single sealed vial. Reconstitute with bacteriostatic water per standard protocol.
How should the blend be stored?
Store lyophilized at -20°C. Post-reconstitution: 4°C for up to 30 days or labeled -80°C aliquots for extended storage.
What related metabolic products are available for GLP-1/amylin research?
Semaglutide 10mg ($149), Cagrilintide 5mg ($99), Retatrutide + Cagrilintide Blend ($199), GLP-2TZ Blend ($199), GLP-3RT Blend ($249), Metabolic Research Stack ($349).
Is the Semaglutide + Cagrilintide Blend for human use?
No. For laboratory research use only. Not for human consumption. Not intended to diagnose, treat, cure, or prevent any disease. —
Research use only. Not for human consumption. Not intended to diagnose, treat, cure, or prevent any disease.
Research documentation
Research use FAQ
What documentation is available for Semaglutide + Cagrilintide Blend Research Peptide?
Semaglutide + Cagrilintide Blend Research Peptide includes research-use product information and should be reviewed alongside the certificate of analysis, quality standards, and batch documentation before laboratory use.
How should researchers review storage guidance for Semaglutide + Cagrilintide Blend Research Peptide?
Researchers should review the product page together with the peptide storage guide for handling expectations, lyophilized material considerations, and documentation practices.
Where can the COA for Semaglutide + Cagrilintide Blend Research Peptide be verified?
COA verification is available through the OligoPoly COA resource, which explains certificate review, identity documentation, and quality-control context.
Is Semaglutide + Cagrilintide Blend Research Peptide intended for human use?
No. OligoPoly products are supplied for laboratory research use only and are not intended for human consumption, clinical use, veterinary use, or diagnostic use.
What quality standards apply to Semaglutide + Cagrilintide Blend Research Peptide?
Researchers should review OligoPoly quality standards, purity documentation, and supporting research-library resources before adding any peptide to a laboratory workflow.
Satisfaction guarantee
OligoPoly Labs wants every research order to arrive accurate, intact, and aligned with the listed documentation. If something is wrong with your order, contact support so the issue can be reviewed under our return and refund policy.
